Physician profile
Alex Bonk
NPI 1962841981
$1,986.69
in general payments reported to CMS, 2019-2025
15 companies · $545 in 2025
The $545 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $15.62 · 2021: $200 · 2022: $182 · 2023: $359 · 2024: $496 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $602.11 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $352.95 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $176.43 | 2021-2025 | Total30, Dailies, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $169.40 | 2019-2021 | |
| Biotissue Holdings INC. | $165.92 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $115.13 | 2021 | |
| Novartis Pharmaceuticals Corporation | $92.57 | 2022-2023 | |
| Johnson & Johnson Vision Care, INC. | $92.41 | 2019-2025 | |
| Abbvie INC. | $62.46 | 2022-2023 | Vuity, Lumigan |
| Coopervision INC. | $46.31 | 2019-2025 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $41.99 | 2022-2023 | Cequa |
| Astellas Pharma Global Development | $20.89 | 2024 | Izervay |
| Allergan, INC. | $18.17 | 2021 | |
| Shire North American Group INC | $15.72 | 2019 | |
| Sight Sciences, INC. | $14.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Bonk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.